KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EBIT Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 81.11%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 3.64%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 12.96%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -203.67%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 11.54%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 14.90%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2.04%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -42.48%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 3.64%
Dec 28, 2025 27.82%
Sep 28, 2025 9.90%
Jun 29, 2025 19.66%
Mar 30, 2025 12.41%
Sep 29, 2024 -8.64%
Jun 30, 2024 1.42%
Mar 31, 2024 -3.59%
Dec 31, 2023 32.29%
Oct 1, 2023 -0.18%
Jul 2, 2023 13.31%
Apr 2, 2023 -0.42%
Jan 1, 2023 32.92%
Oct 2, 2022 -3.08%
Jul 3, 2022 -10.18%
Apr 3, 2022 -6.32%
Oct 3, 2021 6.18%
Jul 4, 2021 5.08%
Apr 4, 2021 5.47%
Jan 3, 2021 40.06%
Sep 27, 2020 8.41%
Jun 28, 2020 -8.87%
Mar 29, 2020 2.57%
Dec 29, 2019 -3.54%
Sep 29, 2019 3.33%
Jun 30, 2019 -1.29%
Mar 31, 2019 -0.14%
Dec 30, 2018 -29.82%
Sep 30, 2018 5.92%
Jul 1, 2018 2.82%
Apr 1, 2018 1.69%
Dec 31, 2017 -9.08%
Oct 1, 2017 -6.70%
Jul 2, 2017 -4.01%
Apr 2, 2017 -1.70%
Jan 1, 2017 3.83%
Oct 2, 2016 2.66%
Jul 3, 2016 3.18%
Apr 3, 2016 2.44%
Jan 3, 2016 40.63%
Sep 27, 2015 2.56%
Jun 28, 2015 2.24%
Mar 29, 2015 5.41%
Dec 28, 2014 37.84%
Sep 28, 2014 12.47%
Jun 29, 2014 16.88%
Mar 30, 2014 7.06%
Dec 29, 2013 -27.31%
Sep 29, 2013 6.62%
Jun 30, 2013 5.65%
Mar 31, 2013 1.22%
Dec 30, 2012 23.64%
Sep 30, 2012 0.32%
Jul 1, 2012 1.86%
Apr 1, 2012 -0.61%